MedTrace Logo

Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study

NCT04508556 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-04-01

No results posted yet for this study

Summary

The primary aim of this study is to investigate the performance of Breath Biopsy RD for the detection of SARS-CoV-2 in both a clinical and at home setting.

Conditions

  • Covid19

Interventions

DEVICE

Breath Biopsy face masks with removable filters and fitted PVA strip

Device developed for collection of breath samples

DIAGNOSTIC_TEST

Nasopharyngeal swab

Is a method for collecting a clinical test sample of nasal secretions from the back of the nose and throat.

DIAGNOSTIC_TEST

oropharyngeal swabs

Is a method for collecting a clinical test sample from the back of the throat.

Sponsors & Collaborators

  • OLVG

    collaborator NETWORK

  • Maastricht University

    collaborator OTHER

  • Owlstone Ltd

    lead INDUSTRY

Principal Investigators

  • Paul Savelkoul, · OLVG

  • Paul Bresser · Maastricht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2020-12-19
Completion
2020-12-19

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04508556 on ClinicalTrials.gov